KMT2A and acute lymphoblastic leukemia: Gale et al. (1997) first described the detection of KMT2A-AFF1 (formerly, MLL-AF4) translocations in newborn DBSs obtained from three patients who were diagnosed with ALL under the age of two years, thus confirming the prenatal development of this initiating lesion among these very young patients [33].